Ganciclovir Sodium

CHEMBL1200850 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
277.2 g/mol
LogP
Phase
4

This sodium salt form of ganciclovir is an intravenous antiviral used to treat cytomegalovirus infections in immunocompromised patients, including CMV retinitis in AIDS patients and CMV disease in transplant recipients. It requires careful monitoring due to potential effects on bone marrow.

Masse moléculaire

277,2100 g/mol

TPSA

142,00 Ų

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1nc([O-])c2ncn(COC(CO)CO)c2n1.[Na+]

InChI

InChI=1S/C9H13N5O4.Na/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16;/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17);/q;+1/p-1

Molecular Formula

C9H12N5NaO4

HBD / HBA

3 / 8

Liaisons Rotatives

5

Atomes Lourds

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This sodium salt form of ganciclovir is an intravenous antiviral used to treat cytomegalovirus infections in immunocompromised patients, including CMV retinitis in AIDS patients and CMV disease in transplant recipients. It requires careful monitoring due to potential effects on bone marrow.

Yes, Ganciclovir Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200850. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23700083. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.